• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病增加了并发炎症性肠病的风险:一项基于韩国全国人口的研究。

Psoriasis increases the risk of concurrent inflammatory bowel disease: A population-based nationwide study in Korea.

作者信息

Lee Jin Yong, Kang Sungchan, Bae Jung Min, Jo Seong Jin, Koh Seong-Joon, Park Hyun-Sun

机构信息

Public Health Medical Service, SMG-SNU Boramae Medical Center, Seoul, Korea.

Institute of Health and Environment, Seoul National University, Seoul, Korea.

出版信息

Indian J Dermatol Venereol Leprol. 2019 Mar-Apr;85(2):145-152. doi: 10.4103/ijdvl.IJDVL_875_17.

DOI:10.4103/ijdvl.IJDVL_875_17
PMID:30058564
Abstract

BACKGROUND

The epidemiology of the association between psoriasis and inflammatory bowel disease is poorly defined and remains controversial.

AIM

To evaluate the prevalence of inflammatory bowel disease in patients with psoriasis compared with the general population.

METHODS

We searched the nationwide health claims database between 2011 and 2015 and evaluated the prevalence of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

RESULTS

Prevalence of inflammatory bowel disease, Crohn's disease and ulcerative colitis in patients with psoriasis vs the general population in 2011 were 0.16, 0.05 and 0.12% vs 0.08, 0.03 and 0.06%, respectively, which increased significantly with time between 2011 and 2015. Patients with psoriasis consistently revealed higher standardized prevalence (age and sex adjusted) of inflammatory bowel disease, Crohn's disease and ulcerative colitis compared with the general population. Subgroup analysis revealed the highest risk of prevalent inflammatory bowel disease in patients younger than 19 years (crude odds ratio 5.33, 95% confidence interval 3.74-7.59). Severe psoriasis demonstrated higher odds of inflammatory bowel disease (odds ratio 2.96, 95% confidence interval 2.54-3.45) than mild psoriasis (odds ratio 1.68, 95% confidence interval 1.51-1.88).

LIMITATIONS

Limited data for doing adjustment and cross-sectional study design.

CONCLUSIONS

Psoriasis patients revealed higher risk of inflammatory bowel disease. In particular, young patients and those with severe psoriasis may require closer monitoring and comprehensive management.

摘要

背景

银屑病与炎症性肠病之间关联的流行病学情况尚不明确,仍存在争议。

目的

评估银屑病患者中炎症性肠病的患病率,并与普通人群进行比较。

方法

我们检索了2011年至2015年的全国健康保险理赔数据库,评估了炎症性肠病(包括克罗恩病和溃疡性结肠炎)的患病率。

结果

2011年银屑病患者中炎症性肠病、克罗恩病和溃疡性结肠炎的患病率分别为0.16%、0.05%和0.12%,而普通人群分别为0.08%、0.03%和0.06%,2011年至2015年期间患病率随时间显著增加。与普通人群相比,银屑病患者炎症性肠病、克罗恩病和溃疡性结肠炎的标准化患病率(年龄和性别校正后)始终较高。亚组分析显示,19岁以下患者患炎症性肠病的风险最高(粗比值比5.33,95%置信区间3.74 - 7.59)。重度银屑病患者患炎症性肠病的几率(比值比2.96,95%置信区间2.54 - 3.45)高于轻度银屑病患者(比值比1.68,95%置信区间1.51 - 1.88)。

局限性

用于调整的数据有限且为横断面研究设计。

结论

银屑病患者患炎症性肠病的风险较高。特别是年轻患者和重度银屑病患者可能需要更密切的监测和综合管理。

相似文献

1
Psoriasis increases the risk of concurrent inflammatory bowel disease: A population-based nationwide study in Korea.银屑病增加了并发炎症性肠病的风险:一项基于韩国全国人口的研究。
Indian J Dermatol Venereol Leprol. 2019 Mar-Apr;85(2):145-152. doi: 10.4103/ijdvl.IJDVL_875_17.
2
Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.澳大利亚普通人群中炎症性肠病的流行情况:一项横断面研究。
PLoS One. 2021 May 27;16(5):e0252458. doi: 10.1371/journal.pone.0252458. eCollection 2021.
3
Increased incidence of inflammatory bowel disease in Québec residents with airway diseases.魁北克地区气道疾病患者中炎症性肠病发病率上升。
Eur Respir J. 2015 Apr;45(4):962-8. doi: 10.1183/09031936.00079414. Epub 2014 Nov 18.
4
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.瑞士炎症性肠病队列中肠外表现的频率和危险因素。
Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.
5
Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.肿瘤坏死因子拮抗剂治疗炎症性肠病患者继发银屑病样疾病的发生率:一项全国基于人群的队列研究。
Aliment Pharmacol Ther. 2018 Jul;48(2):196-205. doi: 10.1111/apt.14822. Epub 2018 Jun 5.
6
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.肥胖对炎症性肠病疾病活动和结局的影响:来自瑞士炎症性肠病队列的研究结果。
United European Gastroenterol J. 2020 Dec;8(10):1196-1207. doi: 10.1177/2050640620954556.
7
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.与炎症性肠病相关的皮肤病患者中炎症性肠病延迟诊断的风险
Inflamm Bowel Dis. 2021 Oct 20;27(11):1731-1739. doi: 10.1093/ibd/izaa344.
8
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.英国炎症性肠病的流行病学和结局变化模式:2000-2018 年。
Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1.
9
Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.炎症性肠病中的贫血:患病率、鉴别诊断及其与临床和实验室指标的关联
Sao Paulo Med J. 2014;132(3):140-6. doi: 10.1590/1516-3180.2014.1323568. Epub 2014 Apr 14.
10
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.

引用本文的文献

1
Incidence of New-Onset Inflammatory Bowel Disease, Oral and Gastrointestinal Candidiasis, Herpes Zoster, Pulmonary Tuberculosis, and Major Cardiovascular Events in Patients with Moderate-to-Severe Psoriasis Exposed to Biologics.暴露于生物制剂的中重度银屑病患者新发炎症性肠病、口腔和胃肠道念珠菌病、带状疱疹、肺结核及主要心血管事件的发生率。
J Clin Med. 2023 Dec 13;12(24):7653. doi: 10.3390/jcm12247653.
2
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis: A Bidirectional 2-Sample Mendelian Randomization Study.炎症性肠病与银屑病及银屑病关节炎之间的关联:一项双向双样本孟德尔随机化研究。
JAMA Dermatol. 2022 Sep 14;158(11):1262-8. doi: 10.1001/jamadermatol.2022.3682.
3
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.
银屑病的流行病学和合并症:一篇叙述性综述。
Front Immunol. 2022 Jun 10;13:880201. doi: 10.3389/fimmu.2022.880201. eCollection 2022.
4
Asymptomatic Crohn's disease identified in a patient being treated with secukinumab: A case report.在接受司库奇尤单抗治疗的患者中发现无症状克罗恩病:一例报告。
SAGE Open Med Case Rep. 2019 Dec 6;7:2050313X19893580. doi: 10.1177/2050313X19893580. eCollection 2019.
5
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.接受司库奇尤单抗治疗的银屑病、银屑病关节炎和强直性脊柱炎患者中炎症性肠病的发生率:21 项临床试验汇总数据的回顾性分析。
Ann Rheum Dis. 2019 Apr;78(4):473-479. doi: 10.1136/annrheumdis-2018-214273. Epub 2019 Jan 23.